News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Researchers seek participants for online psychological support study

November 10, 2020

The study’s findings will be used to inform the development of a psychological intervention for people with MS.
Learn more

Anti-inflammatory therapy slows MS progression in mice

October 30, 2020

Researchers showed delivering an anti-inflammatory drug to mice helped prevent damage to brain cells, effectively slowing the progression of the disease.
Learn more

Researchers seek participants for tele-exercise study

October 28, 2020

This study will examine how effective seated Zoom exercise classes are for a person with CNI for addressing cardiovascular health, physical wellness, and quality of life.
Learn more

Study IDs risk factors for unemployment in people with MS

October 27, 2020

A new study of employment and multiple sclerosis compared two groups of individuals with MS – those 'at risk' and 'not at risk' – for unemployment, examining the influences of multiple factors on the likelihood of staying in the workplace.
Learn more

Cytokine-protein combo may offer treatment for MS

October 21, 2020

The therapy showed few negative side effects, and researchers will next formally study the toxicity of the therapy in hopes of eventually moving it to human clinical trials.
Learn more

Researchers seeking recruits for survey focusing on experiences in accessing mental health treatment

October 09, 2020

The information gathered from the survey is important in helping the researchers identify ways to make access to mental health care easier for families.
Learn more

Study: Pregnancy may delay onset of MS symptoms by more than three years

September 30, 2020

Researchers suggest pregnancy could reduce the abnormal over-activity of the immune system that causes MS, potentially long-term.
Learn more

Survey: COVID-19 has minimal emotional effect for people with progressive MS

September 22, 2020

Findings from a COVID Impact Survey administered during lockdown showed minimal changes in depression, anxiety, and quality of life, and in the impact of MS symptomatology on activities of daily living.
Learn more

Cashew shell compound appears to mend damaged nerves

September 03, 2020

The report includes a range of new findings that point to potential therapeutic use of anacardic acid for demyelinating diseases.
Learn more

Researchers seek participants for online psychological support study

November 10, 2020

The study’s findings will be used to inform the development of a psychological intervention for people with MS.
Learn more

Anti-inflammatory therapy slows MS progression in mice

October 30, 2020

Researchers showed delivering an anti-inflammatory drug to mice helped prevent damage to brain cells, effectively slowing the progression of the disease.
Learn more

Researchers seek participants for tele-exercise study

October 28, 2020

This study will examine how effective seated Zoom exercise classes are for a person with CNI for addressing cardiovascular health, physical wellness, and quality of life.
Learn more

Study IDs risk factors for unemployment in people with MS

October 27, 2020

A new study of employment and multiple sclerosis compared two groups of individuals with MS – those 'at risk' and 'not at risk' – for unemployment, examining the influences of multiple factors on the likelihood of staying in the workplace.
Learn more

Cytokine-protein combo may offer treatment for MS

October 21, 2020

The therapy showed few negative side effects, and researchers will next formally study the toxicity of the therapy in hopes of eventually moving it to human clinical trials.
Learn more

Researchers seeking recruits for survey focusing on experiences in accessing mental health treatment

October 09, 2020

The information gathered from the survey is important in helping the researchers identify ways to make access to mental health care easier for families.
Learn more

Study: Pregnancy may delay onset of MS symptoms by more than three years

September 30, 2020

Researchers suggest pregnancy could reduce the abnormal over-activity of the immune system that causes MS, potentially long-term.
Learn more

Survey: COVID-19 has minimal emotional effect for people with progressive MS

September 22, 2020

Findings from a COVID Impact Survey administered during lockdown showed minimal changes in depression, anxiety, and quality of life, and in the impact of MS symptomatology on activities of daily living.
Learn more

Cashew shell compound appears to mend damaged nerves

September 03, 2020

The report includes a range of new findings that point to potential therapeutic use of anacardic acid for demyelinating diseases.
Learn more

Study: Childhood obesity could increase MS risk

September 03, 2020

Researchers project childhood and adolescent obesity will contribute up to 14 percent of overall risk of MS in 2035.
Learn more

Study suggests protein may be linked to myelin sheath restoration

August 25, 2020

Researchers were able to regenerate damaged myelin sheaths in mice by treating them with the active substance theophylline.
Learn more

FDA approves Kesimpta

August 21, 2020

Kesimpta is the first B-cell therapy that can be self-administered once monthly at home via the Sensoready autoinjector pen.
Learn more

Study: Gene may influence oligodendrocytes

August 18, 2020

Researchers hope the results of the study can help to improve the treatment of MS.
Learn more

Study: Altering reelin levels a possible new treatment for MS

August 14, 2020

Researchers suggest that reducing immune cells’ ability to accumulate and cause inflammation by altering reelin levels could represent a new strategy for treating patients with MS.
Learn more

Special Needs Group launches offer to support MS Focus

August 12, 2020

The organization will donate 10 percent to MS Focus for every Soothie Cushion they sell. This new, ongoing initiative was launched in July.
Learn more

MS mental fatigue linked to slower response to high mental activity

July 30, 2020

The findings suggest significant differences between the two groups in use of brain resources in response to increased mental activity. 
Learn more

MS Focus joins effort to preserve copay help for those with chronic diseases

July 28, 2020

MS Focus joined more than 100 organizations to oppose a provision that would increase barriers to access of care and put individuals struggling with chronic and debilitating diseases at risk
Learn more

Study: Higher severe COVID-19 risk for patients on Ocrevus, Rituxan

July 24, 2020

For most patients with MS, the benefits of remaining on their therapy still outweighs the risk. Individual treatment decisions need to be made between the person with MS and their healthcare team.
Learn more


Show More News